Gresonitamab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Gresonitamab Usage And Synthesis

Uses

Gresonitamab (AMG 910) is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody targets CD3-positive T cells and CLDN18.2-expressing tumor cells. Gresonitamab can be used for the research of adenocarcinoma[1].

References

[1] Cao W, et al. Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy. Biomark Res. 2022 May 31;10(1):38.

Gresonitamab(2413817-97-5)Related Product Information

• Murlentamab
• Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer
• Tavolimab
• Igovomab
• Quisovalimab
• Tecaginlimab
• Enoticumab
• Rulonilimab
• Zelminemab
• Vanucizumab